Sproutly Inc (SRUTF)

[JohnCM]

Early Warning Report for Sproutly Canada, Inc.

Sproutly Canada, Inc. announced on August 1, 2018 that it had completed the acquisition of Infusion Biosciences Canada
Inc. (“Infusion Biosciences Canada”) (the “Acquisition”). Pursuant to the Acquisition, Infusion
BioSciences Inc. (“Infusion Biosciences”) was issued 36,857,676 common shares of Sproutly as
partial payment of the purchase price.

Immediately prior to the sale, Infusion beneficially owned or exercised control or direction over Nil
common shares of Sproutly.

Immediately after the sale, Infusion beneficially owned or exercised control or direction over
36,857,676 common shares of Sproutly, representing approximately 29.74% of the outstanding
common shares of Sproutly.

About Sproutly Canada, Inc.

Sproutly is an ACMPR Licensed Producer of cannabis that strives to meet the evolving needs of
cannabis consumers across Canada and Europe. Its mission is to become a vertically integrated
cannabis consumer products company, bringing together best-in-class cultivation, secure distribution
solutions, and advanced technologies to redefine the cannabis industry. Sproutly, through its wholly
owned subsidiary, owns and operates a 16,600 sq. ft. production facility located centrally in the Greater
Toronto Area utilizing state-of-the-art cultivation technologies and processing methods that meet the
standards for producing pharmaceutical grade products. Sproutly’s strategy is focused on developing
and deploying novel technologies to formulate and market unique cannabis products in the rapidly
evolving consumer market.

For more information on Sproutly please visit www.sproutly.ca.
For further information please contact:
Investor Relations
[e-mail]
Phone: [phone]